Zoetis U.S. — Revenue decreased by 11.8% to $1.09B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 7.9%, from $1.18B to $1.09B. Over 4 years (FY 2021 to FY 2025), U.S. — Revenue shows an upward trend with a 6.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates growing market share or higher demand for animal health products in the U.S., while a decrease may signal competitive pressure or market saturation.
This metric represents the total gross sales generated from products and services sold within the United States market....
Standard revenue reporting for domestic segments across global pharmaceutical and life sciences companies.
zts_segment_u_s_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.00B | $1.07B | $1.04B | $1.02B | $1.09B | $1.09B | $1.11B | $1.01B | $1.17B | $1.17B | $1.21B | $1.16B | $1.31B | $1.35B | $1.26B | $1.18B | $1.36B | $1.32B | $1.24B | $1.09B |
| QoQ Change | — | +6.1% | -2.3% | -1.9% | +7.0% | -0.1% | +2.0% | -9.6% | +15.9% | +0.8% | +3.2% | -4.0% | +12.5% | +2.9% | -6.6% | -5.9% | +14.6% | -2.5% | -6.5% | -11.8% |
| YoY Change | — | — | — | — | +8.7% | +2.3% | +6.9% | -1.5% | +6.8% | +7.7% | +8.9% | +15.7% | +12.3% | +14.7% | +3.8% | +1.7% | +3.7% | -1.8% | -1.7% | -7.9% |